Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 51-75 of 74 citing articles:

End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain
Heather Whitaker, Naoma Willam, Simon Cottrell, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 5
Open Access | Times Cited: 1
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses — IVY Network, September 1, 2022–March 30, 2023
Nathaniel M. Lewis, Elizabeth Harker, Aleda M. Leis, et al.
Vaccine (2024) Vol. 43, pp. 126492-126492
Closed Access | Times Cited: 1
Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland
Louise Marron, Adele McKenna, Joan O’Donnell, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 12
Closed Access | Times Cited: 1
Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States
Mark W. Tenforde, Emily L Reeves, Zachary A. Weber, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 1
Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season
Donatella Panatto, Alexander Domnich, Maria Chironna, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 83-83
Open Access | Times Cited: 7
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study
Caren van Roekel, Eero Poukka, Topi Turunen, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. Supplement_1, pp. S92-S99
Open Access | Times Cited: 4
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)
Takeshi Arashiro, Maki Miwa, Hidenori Nakagawa, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 677-688
Open Access | Times Cited: 2
Influenza incidence and vaccine effectiveness during the Southern Hemisphere Influenza season—Chile, 2022
María Fernanda Olivares Barraza, Rodrigo Fasce, Francisco Nogareda, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 12, pp. 3170-3174
Open Access | Times Cited: 3
Interim 2023/24 season influenza vaccine effectiveness in primary and secondary care in the United Kingdom
Heather Whitaker, Beth Findlay, Jana Zitha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
C. Kevin, Diya Surie, Adam S. Lauring, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Winter 2022–23 influenza vaccine effectiveness against influenza-related hospitalised aLRTD: A test-negative, case-control study
Anastasia Chatzilena, Catherine Hyams, Robert Challen, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126073-126073
Closed Access
Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection
Ryan E. Wiegand, Bruce Fireman, Morgan Najdowski, et al.
Research Square (Research Square) (2024)
Open Access
Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study
Korryn Bodner, Linwei Wang, Rafal Kustra, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Influenza vaccine effectiveness against influenza-associated hospitalizations in children, Hong Kong, November 2023 to June 2024
So Lun Lee, Mike Yat Wah Kwan, Caitriona Murphy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022
Ashish C. Shrestha, Emma Field, Dharshi Thangarajah, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 9
Open Access
Influenza vaccine effectiveness against influenza-associated hospitalizations in children, Hong Kong, November 2023 to June 2024
So Lun Lee, Mike Yat Wah Kwan, Caitriona Murphy, et al.
Vaccine X (2024) Vol. 20, pp. 100570-100570
Open Access
Improved Methods for Vaccine Effectiveness Studies
George N. Okoli, Benjamin J. Cowling
The Journal of Infectious Diseases (2024)
Open Access
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season
Jessie R. Chung, Ashley M. Price, Richard K. Zimmerman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Evaluation of test-negative design estimates of influenza vaccine effectiveness in the context of multiple, co-circulating, vaccine preventable respiratory viruses
Aleda M. Leis, Abram L. Wagner, Brendan Flannery, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126493-126493
Closed Access
Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies
Eero Poukka, Caitriona Murphy, Loretta Mak, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform
Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102995-102995
Open Access
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Lower Respiratory Tract Disease
Sara Y. Tartof, Negar Aliabadi, Guy M. Goodwin, et al.
JAMA Network Open (2024) Vol. 7, Iss. 12, pp. e2450832-e2450832
Open Access
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults
Ashley Tippett, Gabby Ess, Laila Hussaini, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. 1065-1072
Open Access | Times Cited: 1
COVID-19 vaccine effectiveness against hospitalizations in Paraguay, May 2021—April 2022: A test-negative design
Sandra Irala, Sarah Hamid, Elena Penayo, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6453-6460
Closed Access
Previous Page - Page 3

Scroll to top